Aug 31 (Reuters) - Alere Inc alleges Abbott
Laboratories is trying to stymie its planned $5.8
billion takeover of the diagnostics company by purposefully
delaying key submissions to anti-trust regulators, according to
a lawsuit made public on Tuesday.
Read more
No comments:
Post a Comment